Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Etanercept Improves Microvascular Dysfunction in Ankylosing Spondylitis
Link ID 14281
Title Etanercept Improves Microvascular Dysfunction in Ankylosing Spondylitis
Url http://www.medscape.com/viewarticle/589627?src=rss
Description Microvascular function is impaired in patients with ankylosing spondylitis (AS), but improves with treatment with the tumor necrosis factor (TNF)-alpha blocker etanercept, according to a report in the March issue of the Annals of the Rheumatic Diseases. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Mar 17, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Repeated Courses of Rituximab Safe and Effective in Active Rheumatoid Arthritis
  Additional courses of rituximab for patients with active rheumatoid arthritis (RA) who continue to experience symptoms after an initial course of the tumor necrosis factor (TNF) inhibitor induce a sustained and safe clinical response, researchers report in the journal Arthritis and Rheumatism. Reuters Health Information
Category:   Articles > Pharmacists


2. Consider Daptomycin for MRSA With High Vancomycin MICsConsider Daptomycin for MRSA With High Vancomy
  Daptomycin is best for methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection when the vancomycin minimum inhibitory concentration (MIC) is high, researchers say. Reuters Health Information
Category:   Articles > Pharmacists


3. Sustained RA Remission Can Be Achieved Without Biologic Drugs
  Up to 15% of patients with rheumatoid arthritis who were treated with conventional therapy in Dutch and British cohort studies had symptom remission for at least a year, according to a report in the August issue of Arthritis and Rheumatism. Reuters Health Information
Category:   Articles > Pharmacists


4. Denosumab Inhibits Structural Damage in Rheumatoid Arthritis Patients
  Denosumab -- a monoclonal antibody that binds RANKL, which is necessary for osteoclast development -- inhibits structural damage in rheumatoid arthritis patients, according to a report in the May issue of Arthritis & Rheumatism. Reuters Health Information
Category:   Articles > Pharmacists


5. Bisphosphonate-Related Osteonecrosis of the JawBisphosphonate-Related Osteonecrosis of the Jaw
  What does this study really tell dentists and other clinicians? Medscape Dentistry & Oral Health
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS